Article Sidebar

PDF
Issue: No. 84 (2025)
Section: Article
DOI: 10.58490/ctump.2025i84.3305
Date Published: 25/02/2025
Views 250
Downloads 144
How to Cite
Tran, K. N., Nguyen, T. V., Tran, M. H., Nguyen, A. T., Nguyen, T. M. H., & Nguyen, N. C. (2025). A CASE USING HIGH DOSE CORTICOSTEROID IN FACIAL PALSY TREATMENT AFTER TEMPORAL BONE FRACTURE. Cantho Journal of Medicine and Pharmacy, 84, 170-173. https://doi.org/10.58490/ctump.2025i84.3305

A CASE USING HIGH DOSE CORTICOSTEROID IN FACIAL PALSY TREATMENT AFTER TEMPORAL BONE FRACTURE

Khoi Nguyen Tran1, , Trieu Viet Nguyen1, Minh Hanh Tran2, Anh Tuan Nguyen3, Thi My Hanh Nguyen4, Ngoc Chau Nguyen5
1 Can Tho University of Medicine and Pharmacy
2 Can Tho University of Medicine and Pharmacy Hospital
3 Can Tho Pediatric Hospital
4 Nam Can Tho University
5 Ba Tri District General Hospital

Main Article Content

Abstract

Facial paralysis can be happened after a reactivation of Varicella Zoster Virus, cranial neuropathy, cranial trauma with devastating consequences. There are two main approaches for the management of facial paralysis including surgical decompression and oral steroid treatment. Early treatment of facial paralysis brings better experiences, expectation matching and better communication. A 33-year-old male had a serious head trauma, which caused facial paralysis (grade 5 on House-Brackman scale), left temporal bone fracture, subdural hemorrhage. The conservative treatment was indicated, including hig dose corticoid and monitoring the recovery of facial paralysis. After 14 days of high dose corticoid and tappering, the patient recoverd facial movement completely, grade 2 on House-Brackman scale, no intracranial hypertension. High-dose corticosteroid treatment increases the possibility of facial functional recovery. Using corticoid should be continued for more than 14 days.

Keywords

facial paralysis, corticosteroid, corticoid, temporal bone fracture

Article Details

References

1. Geißler K., Urban E., Volk G. F., Klingner C. M., Witte O. W. ea. Non-idiopathic peripheral facial palsy: prognostic factors for outcome. European Archives of Oto-Rhino-Laryngology. 2021. 278(9), 3227-3235, doi: 10.1007/s00405-020-06398-6.
2. Misron K., Tengku K., Tengku M. I., Lamry N. A. Endoscope-assisted facial nerve decompression for traumatic tympanic segment of facial nerve paresis. Proceedings of Singapore Healthcare. 2021. 30(3), 246-249, doi: 10.1177/2010105820963294.
3. Patel A., Groppo E. Management of temporal bone trauma. Craniomaxillofacial trauma & reconstruction. 2010. 3(2), 105-113, doi: 10.1055/s-0030-1254383.
4. Lee P. H., Liang C. C., Huang S. F., Liao H. T. The Outcome Analysis of Traumatic Facial Nerve Palsy Treated With Systemic Steroid Therapy. The Journal of craniofacial surgery. 2018. 29(7), 1842-1847, doi: 10.1097/scs.0000000000004641.
5. Antoniades E, Psillas G. Patient-Assessed Outcomes following Temporal Bone Fractures. 2022. 12(2), doi: 10.3390/diagnostics12020547.
6. Nash J. J., Friedland D. R., Boorsma K. J., Rhee J. S. Management and outcomes of facial paralysis from intratemporal blunt trauma: A systematic review. The Laryngoscope. 2010. 120(7), 1397-1404, doi: 10.1002/lary.20943.
7. Singh G. B., Kumar P., Krishna A. R. A. A Paradigm Shift in the Management of Post Traumatic Complete Facial Nerve Palsy. Indian Journal of Otolaryngology and Head & Neck Surgery. 2020. 72(4), 532-534, doi: 10.1007/s12070-020-01894-x.
8. Abbaszadeh K. A., Kouhi A., Ashtiani M. T. K., Anari M. R., Yazdi A. K. Conservative versus Surgical Therapy in Managing Patients with Facial Nerve Palsy Due to the Temporal Bone Fracture. Craniomaxillofacial trauma & reconstruction. 2019. 12(1), 20-26, doi: 10.1055/s0038-1625966.
9. Phạm Thanh Thúy, Nguyễn Thị Tố Uyên, Đặng Xuân Vinh. Tổng quan về điều trị nội khoa bảo tồn liệt dây thần kinh VII ngoại biên trong chấn thương xương thái dương. Tạp chí Y học Việt Nam. 2023. 522(1), doi: 10.51298/vmj.v522i1.4253.
10. Yadav S, Panda NK, Verma R, Bakshi J, Modi M. Surgery for post-traumatic facial paralysis:
are we overdoing it? European Archives of Oto-Rhino-Laryngology. 2018. 275(11), 2695-2703, doi: 10.1007/s00405-018-5141-y.